D-0378-2025 Class II Ongoing

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0378-2025 was initiated by RemedyRepack Inc. on Mar 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 1,858 30-count blister cards.

Recall details

Product Type
Drugs
Report Date
Apr 30, 2025
Initiation Date
Mar 24, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,858 30-count blister cards

Product description

Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00

Reason for recall

CGMP Deviations

Distribution pattern

PA

Code information

Lot J0826722-121624 Exp. 12/31/2025 Lot J0820365-111324 Exp. 11/30/2025 Lot J0814691-101624 Exp. 10/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0378-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0378-2025. Report a data issue: hello@regdatalab.com.